227 related articles for article (PubMed ID: 37358613)
21. Gd-EOB-DTPA-enhanced MRI T1 mapping for assessment of liver function in rabbit fibrosis model: comparison of hepatobiliary phase images obtained at 10 and 20 min.
Zhou ZP; Long LL; Huang LJ; Yang TF; Huang ZK
Radiol Med; 2017 Apr; 122(4):239-247. PubMed ID: 28070844
[TBL] [Abstract][Full Text] [Related]
22. T
Yang L; Ding Y; Rao S; Chen C; Zeng M
J Magn Reson Imaging; 2021 Mar; 53(3):896-902. PubMed ID: 32979019
[TBL] [Abstract][Full Text] [Related]
23. Ability of dynamic gadoxetic acid-enhanced magnetic resonance imaging combined with water-specific T1 mapping to reflect inflammation in a rat model of early-stage nonalcoholic steatohepatitis.
Wan Q; Peng H; Liu F; Liu X; Cheng C; Tie C; Deng J; Lyu J; Jia Y; Wang Y; Zheng H; Liang D; Liu X; Zou C
Quant Imaging Med Surg; 2024 Feb; 14(2):1591-1601. PubMed ID: 38415124
[TBL] [Abstract][Full Text] [Related]
24. Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry.
Haimerl M; Schlabeck M; Verloh N; Zeman F; Fellner C; Nickel D; Barreiros AP; Loss M; Stroszczynski C; Wiggermann P
Eur Radiol; 2016 Apr; 26(4):1125-33. PubMed ID: 26186960
[TBL] [Abstract][Full Text] [Related]
25. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Vanhooymissen IJSML; Thomeer MG; Braun LMM; Gest B; van Koeverden S; Willemssen FE; Hunink M; De Man RA; Ijzermans JN; Dwarkasing RS
J Magn Reson Imaging; 2019 Mar; 49(3):700-710. PubMed ID: 30252977
[TBL] [Abstract][Full Text] [Related]
26. Effect of Gd-EOB-DTPA on hepatic fat quantification using high-speed T2-corrected multi-echo acquisition in (1)H MR spectroscopy.
Park YS; Lee CH; Kim JH; Kim BH; Kim JH; Kim KA; Park CM
Magn Reson Imaging; 2014 Sep; 32(7):886-90. PubMed ID: 24853467
[TBL] [Abstract][Full Text] [Related]
27. Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time
Haimerl M; Fuhrmann I; Poelsterl S; Fellner C; Nickel MD; Weigand K; Dahlke MH; Verloh N; Stroszczynski C; Wiggermann P
Eur Radiol; 2018 Sep; 28(9):3591-3600. PubMed ID: 29532241
[TBL] [Abstract][Full Text] [Related]
28. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
Chen CY; Chen J; Xia CC; Huang ZX; Song B
J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
[TBL] [Abstract][Full Text] [Related]
29. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI.
Tsuda N; Okada M; Murakami T
Eur J Radiol; 2010 Jan; 73(1):137-42. PubMed ID: 19026502
[TBL] [Abstract][Full Text] [Related]
30. Assessment of liver fibrosis using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance.
Sheng RF; Wang HQ; Yang L; Jin KP; Xie YH; Fu CX; Zeng MS
Dig Liver Dis; 2017 Jul; 49(7):789-795. PubMed ID: 28237298
[TBL] [Abstract][Full Text] [Related]
31. Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.
Ding Y; Rao SX; Chen C; Li R; Zeng MS
Eur Radiol; 2015 May; 25(5):1392-8. PubMed ID: 25523455
[TBL] [Abstract][Full Text] [Related]
32. Non-alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver - a human galactose positron emission tomography study.
Eriksen PL; Thomsen KL; Larsen LP; Grønbaek H; Vilstrup H; Sørensen M
Aliment Pharmacol Ther; 2019 Jul; 50(1):84-92. PubMed ID: 31099410
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
Auer TA; Fehrenbach U; Grieser C; Penzkofer T; Geisel D; Schmelzle M; Müller T; Bläker H; Seehofer D; Denecke T
Eur Radiol; 2020 Jun; 30(6):3497-3506. PubMed ID: 32086574
[TBL] [Abstract][Full Text] [Related]
34. Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging: A preliminary study comparing with
Nakagawa M; Namimoto T; Shimizu K; Morita K; Sakamoto F; Oda S; Nakaura T; Utsunomiya D; Shiraishi S; Yamashita Y
Eur J Radiol; 2017 Jul; 92():116-123. PubMed ID: 28624009
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic.
Zhou ZP; Long LL; Qiu WJ; Cheng G; Huang LJ; Yang TF; Huang ZK
Abdom Radiol (NY); 2017 Sep; 42(9):2272-2278. PubMed ID: 28396918
[TBL] [Abstract][Full Text] [Related]
36. Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort.
Troelstra MA; Witjes JJ; van Dijk AM; Mak AL; Gurney-Champion O; Runge JH; Zwirs D; Stols-Gonçalves D; Zwinderman AH; Ten Wolde M; Monajemi H; Ramsoekh S; Sinkus R; van Delden OM; Beuers UH; Verheij J; Nieuwdorp M; Nederveen AJ; Holleboom AG
J Magn Reson Imaging; 2021 Dec; 54(6):1937-1949. PubMed ID: 33991378
[TBL] [Abstract][Full Text] [Related]
37. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.
Fan Y; Yu Y; Hu M; Wang X; Du M; Guo L; Hu C
Br J Radiol; 2021 Mar; 94(1119):20200950. PubMed ID: 33417489
[TBL] [Abstract][Full Text] [Related]
38. MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis.
Noureddin M; Truong E; Gornbein JA; Saouaf R; Guindi M; Todo T; Noureddin N; Yang JD; Harrison SA; Alkhouri N
J Hepatol; 2022 Apr; 76(4):781-787. PubMed ID: 34798176
[TBL] [Abstract][Full Text] [Related]
39. Liver histology and diffusion-weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study.
Manning P; Murphy P; Wang K; Hooker J; Wolfson T; Middleton MS; Newton KP; Behling C; Awai HI; Durelle J; Paiz MN; Angeles JE; De La Pena D; McCutchan JA; Schwimmer JB; Sirlin CB
J Magn Reson Imaging; 2017 Oct; 46(4):1149-1158. PubMed ID: 28225568
[TBL] [Abstract][Full Text] [Related]
40. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
